Company intelligence / Profile preview

Synata Bio

Warrenville, Illinois, United Statessynatabio.com ↗

Ownership: Private
Development stage: Commercial

Overview

Synata Bio has developed a proprietary gas fermentation technology that converts industrial waste gases—primarily CO2, carbon monoxide, and hydrogen—into valuable products such as ethanol, ethyl acetate, and high-protein animal feed. The process has been demonstrated at pilot scale and is now being deployed at commercial scale through the Sylonto joint venture in China. The first plant will produce approximately 50,000 tons of ethanol per year from on-site waste gases. The company claims its process reduces CO2 emissions by about 4 tons per ton of product produced.

Industry: Non-Drug Biotech

Partnerships

Henan Energy Group/Sylonto joint venture for China commercial facilityHOTO Engineering for engineering/construction support in China

Beyond the preview

Go deeper on Synata Bio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Synata Bio.

Explore the full profile